This Precision Plastics Stock Rises 26% in 1 Year: Can GLP-1 Pens Keep It Going?

This precision plastics stock has risen approximately 26% in one year, from a close of Rs 2,477.60 on 17 September 2025 to around Rs 3,110 on 17 September 2026. Almost all of that gain came between March and August 2026.

The company is Shaily Engineering Plastics Ltd (NSE: SHAILY), a Vadodara-based injection moulder founded in 1987. It now also designs and makes pen injector devices for generic semaglutide, the molecule behind the global weight-loss drug boom. That is why a moulding business carries a market capitalisation of Rs 14,241 crore and trades like a healthcare name.

Click Here – Get Free Investment Predictions

How Has This Precision Plastics Stock Performed Across Time Frames?

Over one year the precision plastics stock gained approximately 25.5%, but the path was rough. It fell to a 52-week low of Rs 1,770.90 on 15 April 2026, then more than doubled to a high of Rs 3,615.20 on 11 August 2026. On 17 September 2026 the Shaily Engineering share price was around Rs 3,110, some 14% below that high.

Period	Start Price (Rs)	Return
1 Month (17 Aug 2026)	3,396.30	Minus 8.4%
6 Months (17 Mar 2026)	2,279.90	Plus 36.4%
1 Year (17 Sep 2025)	2,477.60	Plus 25.5%
3 Years (15 Sep 2023)	358.82	Plus 767%

The three-year figure is adjusted for the five-for-one split that cut face value from Rs 10 to Rs 2 in FY24. No split or bonus fell inside the one-year window, so the 25.5% is pure appreciation. The precision plastics stock was among the stronger names on a screen of NSE small-cap stocks ranked by 1-year return, dated 17 September 2026.

Why Did This Precision Plastics Stock Rise 26% in One Year?

The precision plastics stock rose because healthcare went from a side business to the largest part of the company in about eighteen months. Four dated events between November 2025 and August 2026 did the work.

1. Brokerage Initiation on 25 November 2025

A foreign brokerage began coverage of the Shaily Engineering share with a buy rating and a Rs 4,000 target on 25 November 2025, when the stock closed at Rs 2,496.75. Its case: 550 to 600 million GLP-1 delivery devices needed across India, Canada and Brazil by 2030, and healthcare revenue at the precision plastics stock compounding roughly 96% a year to FY28.

2. A Rs 423 Crore Pen Injector Contract on 25 February 2026

The company signed a four-year agreement worth Rs 423 crore with a domestic pharmaceutical company on 25 February 2026 to supply pen injectors. The Shaily Engineering share price gained about 4.5% the next session to Rs 2,028.70, its biggest one-day move since 9 February 2026.

That turned a demand story into contracted visibility for the precision plastics stock. Pen capacity was already moving from 45 million units a year to 85 million, backed by around Rs 100 crore of capital expenditure funded largely through customer advances.

3. ShailyPen Neo Clearances in May 2026

In the third week of May 2026 the company disclosed that its partner Orbicular Pharmaceutical Technologies had won a tentative approval from the United States drug regulator and a Notice of Compliance from the Canadian health authority for a generic semaglutide injection built on ShailyPen Neo. The product had already cleared the Indian regulator.

ShailyPen Neo is a spring-driven, fixed and variable dose pen taking ISO-standard 3 ml cartridges. A drug-device combination is approved as one product, so clearing the device alongside the molecule builds a barrier a rival supplier cannot cross mid-cycle. That is why the precision plastics stock re-rated.

4. FY26 Results on 21 May 2026 and Q1 FY27 on 10 August 2026

FY26 revenue at the precision plastics stock was Rs 990.67 crore, up 25.91%, with EBITDA of Rs 287.7 crore, a 29.0% margin and net profit of Rs 169.91 crore, up 82.5%. Return on capital employed improved 1,140 basis points to 35.8%.

Q1 FY27, reported on 10 August 2026, held the line. Revenue rose 14% to Rs 280.7 crore, EBITDA 18% to Rs 83.3 crore and the operating margin widened 120 basis points to 29.7%. Healthcare jumped 85% to Rs 142.4 crore, past half of sales for the first time. The precision plastics stock hit its 52-week high the next day.

Check the Univest Screener for Live Fundamentals of High-Return Stocks

What Do the Financials of This Precision Plastics Stock Show?

Margins, not revenue, are doing the work at this precision plastics stock. Operating margin moved from 16.07% in FY23 to 19.34%, 22.78% and 29.0% in FY26, because a pen injector earns far more per kilogram of polymer than a moulded household item.

Net profit went from Rs 35.15 crore in FY23 to Rs 57.29 crore, Rs 93.12 crore and Rs 169.91 crore in FY26, while revenue rose from Rs 611.57 crore to Rs 990.67 crore. Profit at the precision plastics stock grew about four times faster than sales.

Quarter	Revenue (Rs Cr)	EBITDA (Rs Cr)	Operating Margin	Net Profit (Rs Cr)	EPS (Rs)
Jun 2025	248.78	70.39	28.53%	41.12	8.92
Sep 2025	258.93	81.61	31.80%	51.25	11.12
Dec 2025	250.57	66.41	26.51%	37.38	8.11
Mar 2026	240.49	69.29	29.26%	40.16	8.68
Jun 2026	280.92	83.30	29.68%	48.01	10.41

Two quarters in that run were flat on revenue and softer on margin, which dragged the Shaily Engineering share price to its April low. The balance sheet held: debt to equity near 0.25, return on equity 23.71%, and an October 2025 review carried an A-plus rating with a stable outlook for this precision plastics stock.

The IKEA Relationship and the Concentration Problem

Shaily Engineering has supplied the Swedish home furnishings retailer IKEA for years, and that relationship built the company. It is also the biggest structural weakness in this precision plastics stock. A rating review dated 9 October 2025 put the consumer segment at around 71% of FY25 operating income and noted it caters to a single industry player.

The mix is shifting. Consumer fell 9% to Rs 511.3 crore, or 52% of FY26 revenue, while healthcare rose 139% to Rs 392.8 crore and industrial 41% to Rs 86.6 crore. In Q1 FY27 consumer revenue at the precision plastics stock dropped a further 24% to Rs 115.5 crore on weak home furnishings demand in Europe and the United States.

So concentration is shrinking for the wrong reason: the anchor customer is ordering less. Management is evaluating a south India plant for consumer electronics costing around Rs 100 crore. Until that lands, the precision plastics stock is a bet on one relationship cooling gracefully while another scales.

Who Has Been Buying This Precision Plastics Stock?

Foreign institutions nearly doubled their stake in this precision plastics stock in five quarters, from 9.71% in June 2025 to 18.18% in June 2026, while the public float shrank by more than six percentage points.

Shareholder	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	43.72%	43.72%	43.40%	43.40%	41.09%
FIIs	9.71%	11.31%	12.00%	16.74%	18.18%
DIIs	14.14%	13.71%	13.63%	10.60%	14.84%
Public	32.43%	31.27%	30.97%	29.27%	25.89%

The promoter column matters. Holding slipped from 43.40% to 41.09% in the June 2026 quarter after one promoter-group holder's 2.27% stake went to nil. One foreign fund holds 7.80%, so ownership of this precision plastics stock is concentrated on both sides.

What Are the Real Risks in This Precision Plastics Stock?

Valuation comes first. The precision plastics stock trades at a PE of approximately 80.5 against an industry PE of about 35.8, and at roughly 19.9 times book value. On trailing earnings per share of Rs 38.44, the price discounts years of pen volume arriving on schedule.

Customer concentration: Consumer still contributes just over half of revenue and leans on one global retailer. A prolonged slowdown in European and American home furnishings, visible in the 24% Q1 FY27 decline, keeps pulling on the precision plastics stock.

Partner and regulatory dependence: The United States clearance is a tentative approval held by a partner, not a launch. Roughly 23 to 24 pharmaceutical firms are tied up for generic GLP-1, and if many delay, capacity at this precision plastics stock sits idle.

Execution and capital commitment: Scaling to 85 million pens in India while planning a 75 million pen plant in Abu Dhabi involves around Rs 750 crore of investment. FY27 guidance is about 36 million pen injectors, with 25 million more units due by September 2027. Utilisation was 50.2% in Q1 FY27, so a slow ramp hurts returns for the precision plastics stock.

Liquidity and volatility: This is a small-cap with thin daily turnover. On 17 March 2026 the precision plastics stock jumped about 20% in one session to Rs 2,298.10 with no exchange disclosure behind it, and on 28 April 2026 the company told the exchanges a fresh surge was market driven with no undisclosed material events. It is already down about 8% in a month.

Input and currency risk: The same review flagged polymer prices, exchange rates and moderate bargaining power against large customers. Much of what this precision plastics stock sells is exported.

Download the Univest iOS App or Univest Android App to track the Shaily Engineering share price live

Shaily Engineering Share: Analyst View

The analyst case for the Shaily Engineering share turns on one question: how many GLP-1 pens ship in FY28 and FY29, and at what price. The foreign brokerage that began coverage in November 2025 later called this precision plastics stock its top midcap idea for 2026, arguing pen capacity of 80 million units could be in place by mid-2026.

The bearish reading is simpler. Consumer revenue is falling, the precision plastics stock has given up about 8% in a month, and a PE above 80 leaves no room for a missed quarter. Watch healthcare growth, utilisation and whether consumer stops shrinking.

Shaily Engineering Share Price Target

The most recent verified Shaily Engineering share price target is Rs 4,000, set on 25 November 2025 when the stock was at Rs 2,496.75. Against a Shaily Engineering share price of about Rs 3,110 that implies roughly 29% upside, but the target is nearly ten months old and has not been publicly refreshed.

No newer verified Shaily Engineering share price target was available at the time of writing. The reference points are then the 52-week high of Rs 3,615.20, about 16% above here, and the low of Rs 1,770.90. A target rests on pen volume and margin assumptions, and this precision plastics stock can move 20% in a day either way.

Other Stocks to Track From the Same Return Screen

Beyond this precision plastics stock, a screen of NSE small-cap stocks ranked by 1-year return also includes related names such as Varroc with a 1-year return of 31.78%, Black Box at 55.94% and City Union Bank at 52.42%.

Among the names covered from that screen, MTAR Technologies returned 396.53% over one year. Readers can compare this precision plastics stock with the Nifty 50 benchmark and track each of these names on Univest before making any decision.

Conclusion

The 26% one-year gain in this precision plastics stock understates how much changed underneath it. Healthcare went from 21% of revenue in FY25 to 40% in FY26 and 51% in the June 2026 quarter, operating margin widened from 22.78% to 29.68%, and FY26 net profit almost doubled.

Unresolved is the other half. Consumer revenue, anchored by a single global retailer, fell 9% in FY26 and 24% in Q1 FY27. The checklist for the next two quarters is short: pen volumes against the 36 million FY27 guidance, utilisation above 50%, and a steadier consumer order book. Anyone new to this precision plastics stock near a PE of 80 may prefer staggered entries and a stop loss.

Frequently Asked Questions

Which precision plastics stock rose 26% in 1 year?

Ans. Shaily Engineering Plastics Ltd (NSE: SHAILY) is the precision plastics stock that gained approximately 25.5% between 17 September 2025 and 17 September 2026, from Rs 2,477.60 to about Rs 3,110. The move came from pen injectors for generic semaglutide.

Why did the Shaily Engineering share price rise over the past year?

Ans. The Shaily Engineering share price rose because healthcare became its biggest segment. A Rs 423 crore pen injector contract on 25 February 2026, ShailyPen Neo clearances in May 2026 and an 85% jump in healthcare revenue in Q1 FY27 drove the precision plastics stock.

What were Shaily Engineering's Q1 FY27 results?

Ans. Shaily Engineering reported Q1 FY27 revenue of Rs 280.7 crore on 10 August 2026, up 14%, with EBITDA of Rs 83.3 crore and a 29.7% operating margin. Net profit was Rs 48.0 crore and healthcare revenue rose 85% to Rs 142.4 crore, or 51% of sales.

Is Shaily Engineering dependent on IKEA?

Ans. Yes, to a significant degree. A rating review dated 9 October 2025 put the consumer segment at around 71% of FY25 operating income and noted it caters to a single industry player, high customer concentration for the precision plastics stock. That share fell to 52% in FY26.

What is the 52-week high and low of Shaily Engineering?

Ans. The 52-week high is Rs 3,615.20, reached on 11 August 2026, and the 52-week low is Rs 1,770.90, touched on 15 April 2026. The precision plastics stock traded around Rs 3,110 on 17 September 2026, roughly 14% below its high.

Have FIIs increased their stake in Shaily Engineering?

Ans. Yes. Foreign institutional holding in the precision plastics stock rose from 9.71% in June 2025 to 18.18% in June 2026. Promoter holding slipped from 43.72% to 41.09% and the public float fell from 32.43% to 25.89%.

What is the Shaily Engineering share price target?

Ans. The most recent verified Shaily Engineering share price target is Rs 4,000, set by a foreign brokerage on 25 November 2025 when the stock was at Rs 2,496.75. No newer verified target appeared in the sources reviewed, so treat it as a dated estimate.

Is this precision plastics stock expensive at current levels?

Ans. On trailing numbers, yes. The precision plastics stock trades at a PE of approximately 80.5 against an industry PE near 35.8 and about 19.9 times book value. That assumes pen volumes scale from the 36 million units guided for FY27 towards capacity of 85 million.